Published: February 10, 2006
Concorde Subsidiary Appoints Medical Advisor to Its BEVCORP Management Team
Concorde Resources Corp. (OTC: CCDE), is
pleased to announce that its majority-owned subsidiary, BEVCORP
International, Inc., d/b/a Beverly Hills Weight Loss & Wellness®, has
appointed Dr. Peter Holyk to its Medical Advisory team.
Dr. Peter R. Holyk graduated from Tufts University School of Medicine in
Boston, MA in 1978 and received a Bachelor of Science degree in Chemistry,
Magna Cum Laude with High Honors from Seton Hall University in 1974. He
conducted a General Medical Internship at Moses H. Cone Memorial Hospital
in Greensboro, NC from 1978-1979.
His Licensure and Certifications include: North Carolina State Physician's
License, Florida State Physician's License, South Carolina State
Physician's License, Certified, American Board of Ophthalmology and
Certified Nutrition Specialist (CNS).
Other medical accomplishments include: American College of Surgeons,
Fellow; American Academy of Ophthalmology, Fellow; American Board of
Chelation Therapists "Diplomate Candidate;" Nambudripad's Allergy
Elimination Therapy; Mercury Detoxification Investigational Review Board of
GLACM/FDA; American Board of Neural Therapy, and Human Growth Hormone
Investigational Review Board GLACM/FDA.
Past and present professional memberships include: American College for the
Advancement of Medicine, Florida Medical Association, American Academy of
Ophthalmology, Indian River County Medical Society, Contact Lens
Association of Ophthalmologists, Southern Medical Association, Fellow,
American College of Surgeons, American College For The Advancement of
Medicine, International College of Integrative, International Oxidative
Medicine Association, and International College of Advanced Longevity
Medicine.
In addition to authoring several articles and book chapters, Dr. Holyk has
lectured extensively and written numerous newspaper columns. Current
ventures include both radio and television appearances on local and
national shows and an Internet column. Dr. Holyk currently practices
natural hormone replacement therapy, nutrition and supplementation
counseling, wellness, and disease prevention. He founded Contemporary
Health Innovations to help bridge the gap between traditional and
"alternative" medicines for the ultimate betterment of the patient
"Dr. Holyk brings to BEVCORP International a wealth of knowledge, and will
serve as an invaluable asset during the research, and development of new
products. Through careful testing and proper research, Dr. Holyk will be
able to help us in determining which new products can provide the best
results to our target market, and add the greatest value to our company as
a whole," said Kenneth Macdonald, Director of CCDE.
The Private Securities Litigation Reform Act of 1995 provides a safe harbor
for forward-looking statements made on behalf of the company. All such
forward-looking statements are, by necessity, only estimates of future
results and actual results achieved by CCDE may differ materially from
these statements due to a number of factors. CCDE assumes no obligations to
update these forward-looking statements to reflect actual results, changes
in assumptions or changes in other factors affecting such statements. You
should independently investigate and fully understand all risks before
making investment decisions.
Distributed by Market Wire
Copyright © 2012, MarketWire
Copyright © 2012, NewsBlaze,
Daily News